Effectiveness of systemic treatment agents on psoriatic nails: A comparative study

Journal of Drugs in Dermatology

Volumn 12, Issue 9, 2013, Pages 1039-1043

  Demirsoy, Evren Odyakmaz ^a   Kiran, Rebiay ^a   Salman, Selma ^a   Çaǧlayan, Çiǧdem ^a   Aktürk, Aysun Şikar ^a   Bayramgurler, Dilek ^a   Bilen, Nilgün ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ETANERCEPT; ETRETIN; INFLIXIMAB; METHOTREXATE;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAIL PSORIASIS; NAIL PSORIASIS SEVERITY INDEX; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; PHOTOTHERAPY; PROSPECTIVE STUDY; PSORIASIS AREA AND SEVERITY INDEX; SYSTEMIC THERAPY;

ACITRETIN; ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; BIOLOGICAL FACTORS; COMBINED MODALITY THERAPY; DERMATOLOGIC AGENTS; FEMALE; HUMANS; IMMUNOGLOBULIN G; KERATOLYTIC AGENTS; MALE; METHOTREXATE; MIDDLE AGED; NAIL DISEASES; NAILS; ONYCHOLYSIS; PHOTOTHERAPY; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 84883332209     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Kyriakou A, Patsatsi A, Sotiriadis D. Detailed analysis of specific nail psoriasis features and their correlations with clinical parameters: a cross-sectional study. Dermatology. 2011;223(3):222-229.
2. de Jong EM, Seegers BA, Gulinck MK, Boezeman JB, van de Kerkhof PC. Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients. Dermatology. 1996;193(4):300-303.
3. Augustin M, Reich K, Blome C Scher I, Laass A, Radtke MA. Nail psoriasis in Germany: epidemiology and burden of disease. Br J Dermatol. 2010;163(3):580-585.
4. Langley RG, Saurat JH, Reich K; Nail Psoriasis Delphi Expert Panel. Recommendations for the treatment of nail psoriasis in patients with moderate to severe psoriasis: a dermatology expert group consensus. J Eur Acad Dermatol Venereol. 2012;26(3):373-381.
5. Tosti A, Ricotti C, Romanelli P, Cameli N, Piraccini BM. Evaluation of the efficacy of acitretin therapy for nail psoriasis. Arch Dermatol. 2009;145(3):269-271.
6. Sanchez-Regana M, Sola-Ortigosa J, Alsina-Gibert M et al. Nail psoriasis: a retrospective study on the effectiveness of systemic treatments (classical and biological therapy). J Eur Acad Dermatol Venereol. 2011;25:579-586.
7. Gümüşl M, Özdemir M, Mevlitoǧlu I, Bodur S. Evaluation of the efficacy of methotrexate and cyclosporine therapies on psoriatic nails: a one-blind, randomized study. J Eur Acad Dermatol Venereol. 2011;25(9):1080-1084.
8. Saricaoglu H, Oz A, Turan H. Nail psoriasis successfully treated with intralesional methotrexate: case report. Dermatology. 2011;222(1):5-7.
9. Stern DK, Creasey AA, Quijije J, Lebwohl MG. UV-A and UV-B penetration of normal human cadaveric fingernail plate. Arch Dermatol. 2011;147(4):439-441.
10. Rigopoulos D, Gregoriou S, Stratigos A, et al. Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, openlabel study. Br J Dermatol. 2008;159(2):453-456.
11. Luger TA, Barker J, Lambert J, et al. Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-tosevere psoriasis. J Eur Acad Dermatol Venereol. 2009;23(8):896-904.
12. Tan AL, Benjamin M, Toumi H, et al. The relationship between the extensor tendon enthesis and the nail in distal interphalangeal joint disease in psoriatic arthritis-a high-resolution MRI and histological study. Rheumatology (Oxford). 2007;46(2):253-256.
13. Wilson FC, Icen M, Crowson CS, McEvoy MT, Gabriel SE, Kremers HM. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum. 2009;61(2):233-239.
14. Rich P, Scher RK. Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis. J Am Acad Dermatol. 2003;49(2):206-212.